Published in Biomaterials on March 15, 2010
Hyaluronic acid hydrogels for biomedical applications. Adv Mater (2011) 2.51
Hyaluronic acid-based clinical biomaterials derived for cell and molecule delivery in regenerative medicine. J Control Release (2011) 1.36
Hyaluronic acid-based hydrogels functionalized with heparin that support controlled release of bioactive BMP-2. Biomaterials (2012) 1.03
Heparin-functionalized polymeric biomaterials in tissue engineering and drug delivery applications. Acta Biomater (2013) 0.95
Controlled release strategies for bone, cartilage, and osteochondral engineering--Part II: challenges on the evolution from single to multiple bioactive factor delivery. Tissue Eng Part B Rev (2013) 0.90
Tissue specific synthetic ECM hydrogels for 3-D in vitro maintenance of hepatocyte function. Biomaterials (2012) 0.89
In situ tissue regeneration through host stem cell recruitment. Exp Mol Med (2013) 0.87
Specific VEGF sequestering to biomaterials: influence of serum stability. Acta Biomater (2013) 0.81
Effect of semisynthetic extracellular matrix-like hydrogel containing hepatocyte growth factor on repair of femoral neck defect in rabbits. Int J Clin Exp Med (2015) 0.78
Ophthalmic Uses of a Thiol-Modified Hyaluronan-Based Hydrogel. Adv Wound Care (New Rochelle) (2014) 0.78
Delivery of EPC embedded in HA-hydrogels for treatment of acute kidney injury. Biomatter (2013) 0.75
The biology of VEGF and its receptors. Nat Med (2003) 32.13
Angiogenesis in health and disease. Nat Med (2003) 14.02
Mechanochemical switching between growth and differentiation during fibroblast growth factor-stimulated angiogenesis in vitro: role of extracellular matrix. J Cell Biol (1989) 4.85
Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation (1998) 4.10
Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications. Semin Oncol (2002) 3.49
Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J Clin Invest (1994) 3.11
Heparin protects basic and acidic FGF from inactivation. J Cell Physiol (1986) 3.09
Recombinant angiopoietin-1 restores higher-order architecture of growing blood vessels in mice in the absence of mural cells. J Clin Invest (2002) 2.26
Cartilage proteoglycans. Semin Cell Dev Biol (2001) 2.17
In situ crosslinkable hyaluronan hydrogels for tissue engineering. Biomaterials (2003) 2.08
Clinical trials in coronary angiogenesis: issues, problems, consensus: An expert panel summary. Circulation (2000) 2.07
Disulfide cross-linked hyaluronan hydrogels. Biomacromolecules (2002) 2.06
Synthesis and evaluation of injectable, in situ crosslinkable synthetic extracellular matrices for tissue engineering. J Biomed Mater Res A (2006) 1.92
Injectable glycosaminoglycan hydrogels for controlled release of human basic fibroblast growth factor. Biomaterials (2005) 1.79
Inhibition of phagocytosis by high molecular weight hyaluronate. Immunology (1980) 1.67
The effect of hyaluronate and its oligosaccharides on endothelial cell proliferation and monolayer integrity. Exp Cell Res (1989) 1.67
Heparin-regulated release of growth factors in vitro and angiogenic response in vivo to implanted hyaluronan hydrogels containing VEGF and bFGF. Biomaterials (2006) 1.58
Review. Hyaluronan: a powerful tissue engineering tool. Tissue Eng (2006) 1.54
Hydrogel matrix to support stem cell survival after brain transplantation in stroke. Neurorehabil Neural Repair (2010) 1.50
First steps of tumor-related angiogenesis. Lab Invest (1991) 1.48
The role of hyaluronan in tumour neovascularization (review). Int J Cancer (1995) 1.40
Glycosaminoglycan hydrogel films as bio-interactive dressings for wound healing. Biomaterials (2002) 1.38
Development of poly-(D,L-lactide--coglycolide) microsphere formulations containing recombinant human vascular endothelial growth factor to promote local angiogenesis. J Control Release (2001) 1.35
Structural specificity of heparin binding in the fibroblast growth factor family of proteins. Proc Natl Acad Sci U S A (2003) 1.34
Simplifying the extracellular matrix for 3-D cell culture and tissue engineering: a pragmatic approach. J Cell Biochem (2007) 1.32
Evaluating drug efficacy and toxicology in three dimensions: using synthetic extracellular matrices in drug discovery. Acc Chem Res (2007) 1.29
Combining electrospun scaffolds with electrosprayed hydrogels leads to three-dimensional cellularization of hybrid constructs. Biomacromolecules (2008) 1.28
Intramuscular administration of vascular endothelial growth factor induces dose-dependent collateral artery augmentation in a rabbit model of chronic limb ischemia. Circulation (1994) 1.21
Modular extracellular matrices: solutions for the puzzle. Methods (2008) 1.16
Biocompatibility and stability of disulfide-crosslinked hyaluronan films. Biomaterials (2005) 1.15
Hyaluronate inhibition of cell proliferation. Arthritis Rheum (1987) 1.14
Inhibition of tumor growth and angiogenesis by a lysophosphatidic acid antagonist in an engineered three-dimensional lung cancer xenograft model. Cancer (2010) 1.13
Stimulation of in vivo angiogenesis by cytokine-loaded hyaluronic acid hydrogel implants. Biomaterials (2004) 1.13
Release of basic fibroblast growth factor from a crosslinked glycosaminoglycan hydrogel promotes wound healing. Wound Repair Regen (2007) 1.12
Stimulation of in vivo angiogenesis using dual growth factor-loaded crosslinked glycosaminoglycan hydrogels. Biomaterials (2006) 1.08
Application of angiogenic oligosaccharides of hyaluronan increases blood vessel numbers in rat skin. J Invest Dermatol (1994) 1.06
Engineering a clinically-useful matrix for cell therapy. Organogenesis (2008) 1.06
Dual growth factor-induced angiogenesis in vivo using hyaluronan hydrogel implants. Biomaterials (2005) 1.05
Improved endothelialization of vascular grafts by local release of growth factor from heparinized collagen matrices. J Control Release (2000) 1.02
Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer. Oncol Rep (2002) 1.01
Synergistic effect of hyaluronan oligosaccharides and vascular endothelial growth factor on angiogenesis in vitro. Lab Invest (1996) 1.00
Recruitment of endogenous stem cells for tissue repair. Macromol Biosci (2008) 0.99
Microvascular maturity elicited in tissue treated with cytokine-loaded hyaluronan-based hydrogels. Biomaterials (2008) 0.96
Evaluating dual activity LPA receptor pan-antagonist/autotaxin inhibitors as anti-cancer agents in vivo using engineered human tumors. Prostaglandins Other Lipid Mediat (2009) 0.96
Effect of gelatin on heparin regulation of cytokine release from hyaluronan-based hydrogels. Drug Deliv (2008) 0.96
Modulation of angiogenesis in vitro by laminin-entactin complex. Dev Biol (1994) 0.91
Physiological and pathological angiogenesis in the endocrine system. Microsc Res Tech (2003) 0.89
Substrate-bonded hyaluronic acid exhibits a size-dependent stimulation of chondrogenic differentiation of stage 24 limb mesenchymal cells in culture. Dev Biol (1986) 0.86
Glycosaminoglycan hydrogels as supplemental wound dressings for donor sites. J Burn Care Rehabil (2004) 0.84
Does hyaluronan have a role in endothelial cell proliferation of the synovium? Semin Arthritis Rheum (1992) 0.81
The role of growth factors, angiogenic enzymes and apoptosis in neovascularization and tumor growth-collected publications. Verh K Acad Geneeskd Belg (2002) 0.79
Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat Med (2005) 8.49
A PtdInsP(3)- and Rho GTPase-mediated positive feedback loop regulates neutrophil polarity. Nat Cell Biol (2002) 5.58
Discovering modes of action for therapeutic compounds using a genome-wide screen of yeast heterozygotes. Cell (2004) 4.91
Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progression. Cancer Cell (2011) 3.47
The PHD finger of the chromatin-associated protein ING2 functions as a nuclear phosphoinositide receptor. Cell (2003) 3.36
Phenotype and genotype of pancreatic cancer cell lines. Pancreas (2010) 3.06
Identification of an intracellular receptor for lysophosphatidic acid (LPA): LPA is a transcellular PPARgamma agonist. Proc Natl Acad Sci U S A (2002) 3.01
Hyaluronic acid hydrogels for biomedical applications. Adv Mater (2011) 2.51
Hyaluronan-binding proteins: tying up the giant. J Biol Chem (2001) 2.20
In situ crosslinkable hyaluronan hydrogels for tissue engineering. Biomaterials (2003) 2.08
Analysis of oxysterol binding protein homologue Kes1p function in regulation of Sec14p-dependent protein transport from the yeast Golgi complex. J Cell Biol (2002) 2.07
Disulfide cross-linked hyaluronan hydrogels. Biomacromolecules (2002) 2.06
Protein pyrophosphorylation by inositol pyrophosphates is a posttranslational event. Proc Natl Acad Sci U S A (2007) 2.03
Synthesis and evaluation of injectable, in situ crosslinkable synthetic extracellular matrices for tissue engineering. J Biomed Mater Res A (2006) 1.92
Lysophosphatidic acid induces neointima formation through PPARgamma activation. J Exp Med (2004) 1.86
Photoreceptor cGMP phosphodiesterase delta subunit (PDEdelta) functions as a prenyl-binding protein. J Biol Chem (2003) 1.80
Injectable glycosaminoglycan hydrogels for controlled release of human basic fibroblast growth factor. Biomaterials (2005) 1.79
Fluorogenic phospholipids as head group-selective reporters of phospholipase A activity. ACS Chem Biol (2006) 1.70
Disulfide-crosslinked hyaluronan-gelatin hydrogel films: a covalent mimic of the extracellular matrix for in vitro cell growth. Biomaterials (2003) 1.69
Vocal fold tissue repair in vivo using a synthetic extracellular matrix. Tissue Eng (2006) 1.66
Heparin-regulated release of growth factors in vitro and angiogenic response in vivo to implanted hyaluronan hydrogels containing VEGF and bFGF. Biomaterials (2006) 1.58
Reduced postoperative intra-abdominal adhesions using Carbylan-SX, a semisynthetic glycosaminoglycan hydrogel. Fertil Steril (2006) 1.55
Dual activity lysophosphatidic acid receptor pan-antagonist/autotaxin inhibitor reduces breast cancer cell migration in vitro and causes tumor regression in vivo. Cancer Res (2009) 1.54
LPA-producing enzyme PA-PLA₁α regulates hair follicle development by modulating EGFR signalling. EMBO J (2011) 1.48
Lysophosphatidic acid is constitutively produced by human peritoneal mesothelial cells and enhances adhesion, migration, and invasion of ovarian cancer cells. Cancer Res (2006) 1.45
Phosphatidylinositol 4,5-bisphosphate regulates inspiratory burst activity in the neonatal mouse preBötzinger complex. J Physiol (2007) 1.44
Elephant albumin: a multipurpose pheromone shuttle. Chem Biol (2004) 1.41
Electrospun three-dimensional hyaluronic acid nanofibrous scaffolds. Biomaterials (2006) 1.40
Osteochondral defect repair with autologous bone marrow-derived mesenchymal stem cells in an injectable, in situ, cross-linked synthetic extracellular matrix. Tissue Eng (2006) 1.38
Glycosaminoglycan hydrogel films as bio-interactive dressings for wound healing. Biomaterials (2002) 1.38
Multivalent mechanism of membrane insertion by the FYVE domain. J Biol Chem (2003) 1.38
Inverse association between adiposity and telomere length: The Fels Longitudinal Study. Am J Hum Biol (2010) 1.37
Inositol hexakisphosphate mobilizes an endomembrane store of calcium in guard cells. Proc Natl Acad Sci U S A (2003) 1.37
Attachment and spreading of fibroblasts on an RGD peptide-modified injectable hyaluronan hydrogel. J Biomed Mater Res A (2004) 1.37
Fluorogenic phospholipid substrate to detect lysophospholipase D/autotaxin activity. Org Lett (2006) 1.34
Myristoylated alanine-rich C kinase substrate (MARCKS) sequesters spin-labeled phosphatidylinositol 4,5-bisphosphate in lipid bilayers. J Biol Chem (2002) 1.34
Fibronectin functional domains coupled to hyaluronan stimulate adult human dermal fibroblast responses critical for wound healing. Tissue Eng (2006) 1.33
Alpha-substituted phosphonate analogues of lysophosphatidic acid (LPA) selectively inhibit production and action of LPA. ChemMedChem (2007) 1.32
A PHD finger motif in the C terminus of RAG2 modulates recombination activity. J Biol Chem (2005) 1.31
Rheological properties of cross-linked hyaluronan-gelatin hydrogels for tissue engineering. Macromol Biosci (2009) 1.30
Rheological characterization of in situ cross-linkable hyaluronan hydrogels. Biomacromolecules (2005) 1.30
Combining electrospun scaffolds with electrosprayed hydrogels leads to three-dimensional cellularization of hybrid constructs. Biomacromolecules (2008) 1.28
In vivo engineering of the vocal fold extracellular matrix with injectable hyaluronic acid hydrogels: early effects on tissue repair and biomechanics in a rabbit model. Ann Otol Rhinol Laryngol (2005) 1.23
Synthesis and characterization of novel thiol-reactive poly(ethylene glycol) cross-linkers for extracellular-matrix-mimetic biomaterials. Biomacromolecules (2007) 1.22
Low anticoagulant heparin targets multiple sites of inflammation, suppresses heparin-induced thrombocytopenia, and inhibits interaction of RAGE with its ligands. Am J Physiol Cell Physiol (2010) 1.21
Bioprinting vessel-like constructs using hyaluronan hydrogels crosslinked with tetrahedral polyethylene glycol tetracrylates. Biomaterials (2010) 1.19
Photoaffinity antigens for human gammadelta T cells. J Immunol (2008) 1.19
Screening for pancreatic cancer: why, how, and who? Ann Surg (2013) 1.19
Enantioselective responses to a phosphorothioate analogue of lysophosphatidic acid with LPA3 receptor-selective agonist activity. J Med Chem (2003) 1.18
Lysophosphatidic acid production and action: validated targets in cancer? J Cell Biochem (2004) 1.17
Modular extracellular matrices: solutions for the puzzle. Methods (2008) 1.16
Synthesis of monofluorinated analogues of lysophosphatidic acid. J Org Chem (2003) 1.15
Autotaxin production of lysophosphatidic acid mediates allergic asthmatic inflammation. Am J Respir Crit Care Med (2013) 1.15
Biocompatibility and stability of disulfide-crosslinked hyaluronan films. Biomaterials (2005) 1.15
A monoclonal antibody to visualize PtdIns(3,4,5)P(3) in cells. J Histochem Cytochem (2002) 1.14
Tumor engineering: orthotopic cancer models in mice using cell-loaded, injectable, cross-linked hyaluronan-derived hydrogels. Tissue Eng (2007) 1.14
Functional performance of human cardiosphere-derived cells delivered in an in situ polymerizable hyaluronan-gelatin hydrogel. Biomaterials (2012) 1.14
Prevention of peritendinous adhesions using a hyaluronan-derived hydrogel film following partial-thickness flexor tendon injury. J Orthop Res (2008) 1.13
Pulmonary autotaxin expression contributes to the pathogenesis of pulmonary fibrosis. Am J Respir Cell Mol Biol (2012) 1.13
Inhibition of tumor growth and angiogenesis by a lysophosphatidic acid antagonist in an engineered three-dimensional lung cancer xenograft model. Cancer (2010) 1.13
Identification and biophysical characterization of a very-long-chain-fatty-acid-substituted phosphatidylinositol in yeast subcellular membranes. Biochem J (2004) 1.13
Crosslinked hyaluronan hydrogels containing mitomycin C reduce postoperative abdominal adhesions. Fertil Steril (2005) 1.12
Nuclear magnetic resonance metabolomic footprinting of human hepatic stem cells and hepatoblasts cultured in hyaluronan-matrix hydrogels. Stem Cells (2008) 1.12
Release of basic fibroblast growth factor from a crosslinked glycosaminoglycan hydrogel promotes wound healing. Wound Repair Regen (2007) 1.12
Layer by layer buildup of polysaccharide films: physical chemistry and cellular adhesion aspects. Langmuir (2004) 1.12
Impaired transcriptional activity of Nrf2 in age-related myocardial oxidative stress is reversible by moderate exercise training. PLoS One (2012) 1.10
Regulation of lysophosphatidic acid receptor expression and function in human synoviocytes: implications for rheumatoid arthritis? Mol Pharmacol (2007) 1.10
Early detection of sporadic pancreatic cancer: summative review. Pancreas (2015) 1.10
Stimulation of in vivo angiogenesis using dual growth factor-loaded crosslinked glycosaminoglycan hydrogels. Biomaterials (2006) 1.08
Lipid phosphate phosphatases regulate lysophosphatidic acid production and signaling in platelets: studies using chemical inhibitors of lipid phosphate phosphatase activity. J Biol Chem (2003) 1.07
Intracellular delivery of phosphatidylinositol (3,4,5)-trisphosphate causes incorporation of glucose transporter 4 into the plasma membrane of muscle and fat cells without increasing glucose uptake. J Biol Chem (2004) 1.06
Sustained activation of nuclear erythroid 2-related factor 2/antioxidant response element signaling promotes reductive stress in the human mutant protein aggregation cardiomyopathy in mice. Antioxid Redox Signal (2011) 1.06
Dual growth factor-induced angiogenesis in vivo using hyaluronan hydrogel implants. Biomaterials (2005) 1.05
Chemical synthesis and molecular recognition of phosphatase-resistant analogues of phosphatidylinositol-3-phosphate. J Am Chem Soc (2006) 1.05
Synthetic extracellular matrix enhances tumor growth and metastasis in an orthotopic mouse model of pancreatic adenocarcinoma. J Gastrointest Surg (2007) 1.05
Augmentation of integrin-mediated mechanotransduction by hyaluronic acid. Biomaterials (2013) 1.05
Stabilized phosphatidylinositol-5-phosphate analogues as ligands for the nuclear protein ING2: chemistry, biology, and molecular modeling. J Am Chem Soc (2007) 1.05
The three-dimensional vascularization of growth factor-releasing hybrid scaffold of poly (epsilon-caprolactone)/collagen fibers and hyaluronic acid hydrogel. Biomaterials (2011) 1.05
Disruption of Nrf2/ARE signaling impairs antioxidant mechanisms and promotes cell degradation pathways in aged skeletal muscle. Biochim Biophys Acta (2012) 1.04
Hyaluronic acid-based hydrogels functionalized with heparin that support controlled release of bioactive BMP-2. Biomaterials (2012) 1.03
Concise synthesis of acyl migration-blocked 1,1-difluorinated analogues of lysophosphatidic acid. J Org Chem (2002) 1.03
Inositol polyphosphates, diphosphoinositol polyphosphates and phosphatidylinositol polyphosphate lipids: structure, synthesis, and development of probes for studying biological activity. Nat Prod Rep (2010) 1.03
Adipose tissue engineering with naturally derived scaffolds and adipose-derived stem cells. Biomaterials (2007) 1.02
Targeted delivery of doxorubicin by HPMA copolymer-hyaluronan bioconjugates. Pharm Res (2002) 1.01
Regulation of hepatic stem/progenitor phenotype by microenvironment stiffness in hydrogel models of the human liver stem cell niche. Biomaterials (2011) 1.01
Reprogramming cardiomyocyte mechanosensing by crosstalk between integrins and hyaluronic acid receptors. J Biomech (2011) 1.00
A cross-linked hyaluronan gel accelerates healing of corneal epithelial abrasion and alkali burn injuries in rabbits. Vet Ophthalmol (2010) 1.00
Synthesis of migration-resistant hydroxyethoxy analogues of lysophosphatidic acid. Org Lett (2003) 0.99
Intracellular uptake and trafficking of Pluronic micelles in drug-sensitive and MDR cells: effect on the intracellular drug localization. J Pharm Sci (2002) 0.99
Recruitment of endogenous stem cells for tissue repair. Macromol Biosci (2008) 0.99
Photocrosslinkable hyaluronan-gelatin hydrogels for two-step bioprinting. Tissue Eng Part A (2010) 0.99
Use of hyaluronan-derived hydrogels for three-dimensional cell culture and tumor xenografts. Curr Protoc Cell Biol (2008) 0.98
Serum osteopontin and tissue inhibitor of metalloproteinase 1 as diagnostic and prognostic biomarkers for pancreatic adenocarcinoma. Pancreas (2013) 0.98